Owner MediGene AG

Convention DE 29 November 2004 304 67 582.2/05

Filing Date 27 May 2005

Class 5 Medicines for humans and animals, in particular in the form of serums and diagnostic preparations for medical purposes and therapeutic use, in particular medicines for treating tumorous diseases such as gliomas, carcinomas of the colon, ovarian carcinomas, cervical carcinomas, carcinomas of the prostate, melanomas, basal cell carcinomas, actinic keratosis, breast cancers, bone cancers, brain cancers, colon cancers, endocrine system cancers, gastrointestinal cancers, gynaecological cancers, head and neck cancers, leukemias, lung cancers, lymphomas, metastases, myelomas, pediatric cancers, penile cancers, sarcomas, skin cancers, testicular cancers, thyroid cancers, urinary tract cancers, pleural cancers, neuronal cancers, mesotheliomas, astrocytomas, oligodendrogliomas, meningiomas, neurofibromas, glioblastomas, ependymomas, schwannomas, neurofibrosarcomas, neuroblastomas, pituitary gland cancers, cancers of the hypophysis, medulloblastomas, renal cell carcinomas, pancreatic cancers, gastric cancers, bladder cancers, liver cancers, prostate cancer, fibrosarcomas, squamous cell carcinomas, neuroectodermal cancers, hodgkin's lymphomas, non-hodgkin's lymphomas, hepatomas, epidermal carcinomas, or medicines for treating chronic inflammatory diseases such as rheumatoid arthritis, autoimmune diseases, allergies, multiple sclerosis; medicines for stimulating wound healing; medicines for treating eye diseases and arteriosclerosis (calcification of the arteries); medicines for treating cardiovascular illnesses, in particular hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for treating skin diseases, in particular warts, genital warts and herpes; excluding medicines for enemas and for the preparation of a coloscopy

Class 42 Services of a molecular biological or pharmaceutical laboratory, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy by means of molecular biological, genetic engineering, biotechnological, chemical and pharmaceutical methods, as well as in the field of formulation of pharmaceuticals, of screening for compounds with pharmaceutically effective properties; development of testing processes and test kits